You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 29, 2024

Details for Patent: 8,415,337


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,415,337 protect, and when does it expire?

Patent 8,415,337 protects NEOPROFEN and is included in one NDA.

Summary for Patent: 8,415,337
Title:Ibuprofen compositions and methods of making same
Abstract: The present invention provides an improved ibuprofen lysine pharmaceutical composition and a process for preparing the same.
Inventor(s): Krishna; Aravind (Skillman, NJ)
Assignee: Recordati Rare Diseases Inc. (Lebanon, NJ)
Application Number:13/410,989
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,415,337
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Delivery; Formulation;

Drugs Protected by US Patent 8,415,337

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Recordati Rare NEOPROFEN ibuprofen lysine INJECTABLE;INTRAVENOUS 021903-001 Apr 13, 2006 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.